Publication:
Leucine supplementation protects from insulin resistance by regulating adiposity levels.

dc.contributor.authorBinder, Elke
dc.contributor.authorBermúdez-Silva, Francisco J
dc.contributor.authorAndré, Caroline
dc.contributor.authorElie, Melissa
dc.contributor.authorRomero-Zerbo, Silvana Y
dc.contributor.authorLeste-Lasserre, Thierry
dc.contributor.authorBelluomo, Llaria
dc.contributor.authorDuchampt, Adeline
dc.contributor.authorClark, Samantha
dc.contributor.authorAubert, Agnes
dc.contributor.authorMezzullo, Marco
dc.contributor.authorFanelli, Flaminia
dc.contributor.authorPagotto, Uberto
dc.contributor.authorLayé, Sophie
dc.contributor.authorMithieux, Gilles
dc.contributor.authorCota, Daniela
dc.contributor.authoraffiliation[Binder,E; Bermúdez-Silva,FJ; André,C; Elie,M; Romero-Zerbo,SY; Lester-Lasserre,T; Belluomo,I; Clark,S; Cota,D] INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Bordeaux, France. [Binder,E; Bermúdez-Silva,FJ; André,C; Elie,M; Romero-Zerbo,SY; Lester-Lasserre,T; Belluomo,I, Clark,S] Université de Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Bordeaux, France. [Bermúdez-Silva,FJ; Romero-Zerbo,SY] IBIMA-Hospital Carlos Haya, Laboratorio de Investigación, Malaga, Spain. [Duchampt,A; Mithieux,G] INSERM, Lyon, France. [Duchampt,A; Mithieux,G; Cota,D] Université de Lyon, Lyon, France. [Duchampt,A; Mithieux,G] Université Lyon 1, Villeurbanne, France. [Aubert,A; Layé,S] Nutrition et Neurobiologie Intégrée, Université de Bordeaux, Bordeaux, France. INRA, Nutrition et Neurobiologie Intégrée, Bordeaux, France. [Mezzullo,M; Fanelli,F] Endocrinology Unit and Centro di Ricerca Biomedica Applicata, Department of Clinical Medicine, S.Orsola-Malpighi Hospital, Alma Mater University of Bologna, Bologna, Italy.es
dc.contributor.funderThis work was supported by INSERM, Aquitaine Region, Ajinomoto 3ARP research program, ANR-2010-1414-01 and EquipEx OptoPath ANR-10-EQPX-08 (to DC), European Community’s Seventh Framework Programme FP7-People2009-IEF-251494 (DC and EB) and Fondation Recherche Médicale. FJBS is recipient of a research contract from the National System of Health (Instituto de Salud Carlos III; CP07/00283) and of a BAE from Instituto de Salud Carlos III (BA09/90066).
dc.date.accessioned2014-03-24T13:13:54Z
dc.date.available2014-03-24T13:13:54Z
dc.date.issued2013-09-25
dc.descriptionJournal Article; Research Support, Non-U.S. Gov't;es
dc.description.abstractBACKGROUND Leucine supplementation might have therapeutic potential in preventing diet-induced obesity and improving insulin sensitivity. However, the underlying mechanisms are at present unclear. Additionally, it is unclear whether leucine supplementation might be equally efficacious once obesity has developed. METHODOLOGY/PRINCIPAL FINDINGS Male C57BL/6J mice were fed chow or a high-fat diet (HFD), supplemented or not with leucine for 17 weeks. Another group of HFD-fed mice (HFD-pairfat group) was food restricted in order to reach an adiposity level comparable to that of HFD-Leu mice. Finally, a third group of mice was exposed to HFD for 12 weeks before being chronically supplemented with leucine. Leucine supplementation in HFD-fed mice decreased body weight and fat mass by increasing energy expenditure, fatty acid oxidation and locomotor activity in vivo. The decreased adiposity in HFD-Leu mice was associated with increased expression of uncoupling protein 3 (UCP-3) in the brown adipose tissue, better insulin sensitivity, increased intestinal gluconeogenesis and preservation of islets of Langerhans histomorphology and function. HFD-pairfat mice had a comparable improvement in insulin sensitivity, without changes in islets physiology or intestinal gluconeogenesis. Remarkably, both HFD-Leu and HFD-pairfat mice had decreased hepatic lipid content, which likely helped improve insulin sensitivity. In contrast, when leucine was supplemented to already obese animals, no changes in body weight, body composition or glucose metabolism were observed. CONCLUSIONS/SIGNIFICANCE These findings suggest that leucine improves insulin sensitivity in HFD-fed mice by primarily decreasing adiposity, rather than directly acting on peripheral target organs. However, beneficial effects of leucine on intestinal gluconeogenesis and islets of Langerhans's physiology might help prevent type 2 diabetes development. Differently, metabolic benefit of leucine supplementation is lacking in already obese animals, a phenomenon possibly related to the extent of the obesity before starting the supplementation.es
dc.description.versionYeses
dc.identifier.citationBinder E, Bermúdez-Silva FJ, André C, Elie M, Romero-Zerbo SY, Leste-Lasserre T, et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. PLoS ONE. 2013; 8(9):e74705es
dc.identifier.doi10.1371/journal.pone.0074705
dc.identifier.essn1932-6203
dc.identifier.pmcPMC3783457
dc.identifier.pmid24086364
dc.identifier.urihttp://hdl.handle.net/10668/1545
dc.journal.titlePloS one
dc.language.isoen
dc.publisherPublic Library of Sciencees
dc.relation.publisherversionhttp://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0074705es
dc.rights.accessRightsopen access
dc.subjectPérdida de pesoes
dc.subjectLeptinaes
dc.subjectAminoácidoses
dc.subjectRatoneses
dc.subjectObesidades
dc.subjectAlimentación rica en grasaes
dc.subjectColesteroles
dc.subjectHomeostasises
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Weight::Body Weight Changes::Weight Losses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Adipokines::Leptines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Amino Acidses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Micees
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Weight::Overweight::Obesityes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Diet, High-Fates
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Sterols::Cholesteroles
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Homeostasises
dc.titleLeucine supplementation protects from insulin resistance by regulating adiposity levels.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BinderE_LeucineSupplementation.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado